Epidermolysis bullosa acquisita
Journal of the European Academy of Dermatology and Venereology, 2013 AbstractEpidermolysis bullosa acquisita (EBA) is a chronic autoimmune subepidermal bullous disease with clinical features similar to the genetic form of dystrophic epidermolysis bullosa. EBA is characterized by the presence of autoantibodies against type VII collagen which is a major component of the anchoring fibrils at the dermal‐epidermal junction ...
J H, Kim, S-C, Kim
core +5 more sources
Epidermolysis bullosa acquisita treated with rituximab. [PDF]
BMJ Case Rep, 2021 © BMJ Publishing Group Limited 2021. No commercial reuse. See rights and permissions. Published by BMJ. DESCRIPTION We report the case of a 69yearold male patient, observed for vesiculobullous lesions involving the oral mucosa (figure 1), trunk and ...
Mendes SR, Coutinho I, Cardoso JC.
europepmc +2 more sources
JAMA Dermatol, 2021 Importance Immunoglobulin A (IgA) epidermolysis bullosa acquisita (EBA) is an autoimmune skin blistering disease with IgA autoantibodies directed against type VII collagen.
Becker M +4 more
europepmc +2 more sources
Topical Application of the PI3Kβ-Selective Small Molecule Inhibitor TGX-221 Is an Effective Treatment Option for Experimental Epidermolysis Bullosa Acquisita. [PDF]
Front Med (Lausanne), 2021 Class I phosphoinositide 3-kinases (PI3K) have been implemented in pathogenesis of experimental epidermolysis bullosa acquisita (EBA), an autoimmune skin disease caused by type VII collagen (COL7) autoantibodies.
Zillikens H +16 more
europepmc +2 more sources
Epidermolysis bullosa acquisita: an uncommon cause of esophageal stricture. [PDF]
Oxf Med Case Reports, 2021 Epidermolysis bullosa acquisita (EBA) encompasses a wide spectrum of rare diseases with a common genetic origin transmitted in an autosomal recessive fashion.
Figueredo C, Boroda K, Hertan H.
europepmc +2 more sources
Preventive but Not Therapeutic Topical Application of Local Anesthetics Can Inhibit Experimental Epidermolysis Bullosa Acquisita in Mice. [PDF]
Front Immunol, 2021 Epidermolysis bullosa acquisita (EBA) is an autoimmune blistering disorder characterized and caused by autoantibodies against type VII collagen (COL7).
Wen L +8 more
europepmc +2 more sources
The development of mucous membrane epidermolysis bullosa acquisita in a pediatric patient. [PDF]
JAAD Case Rep, 2021 DRESS: drug rash with eosinophilia and systemic symptoms EBA: epidermolysis bullosa acquisita IIF: indirect immunofluorescence IVIG: intravenous immunoglobulin MM-EBA: mucous membrane epidermolysis bullosa acquisita INTRODUCTION Autoimmune diseases have ...
Rentfro K, Arthur M.
europepmc +2 more sources
An atypical case of pediatric epidermolysis bullosa acquisita: Review of diagnosis and pitfalls. [PDF]
JAAD Case Rep, 2021 BSLE: bullous systemic lupus erythematosus DIF: direct immunofluorescence EBA: epidermolysis bullosa acquisita SLE: systemic lupus erythematosus INTRODUCTION Epidermolysis bullosa acquisita (EBA) is a rare autoimmune blistering disorder, with\50 ...
Patel A, Wanat K, Lalor L.
europepmc +2 more sources
Journal of the Egyptian Women’s Dermatologic SocietyEpidermolysis Bullosa Acquisita is a rare, chronic autoimmune blistering disorder characterized by vesicles and bullae on the skin and mucous membranes.
Fahad Alrashidi +2 more
doaj +2 more sources
An Exceedingly Rare Case of Mechanobullous Epidermolysis Bullosa Acquisita in a Prepubertal Child: A Review of the Clinical and Laboratory Considerations [PDF]
AntibodiesIntroduction: Epidermolysis bullosa acquisita (EBA) is a rare autoimmune disease causing subepithelial blistering due to autoantibodies against type VII collagen.
Aleksandra Wiktoria Bratborska +3 more
doaj +2 more sources